ClinicalTrials.Veeva

Menu

Factors Influencing Wound Healing After Anal Fistula Surgery

T

Taichung Veterans General Hospital

Status

Not yet enrolling

Conditions

Anal Fistula Surgery

Treatments

Other: NewEpi Plus Liquid Wound Dressing
Other: standard wound care

Study type

Observational

Funder types

Other

Identifiers

NCT06592157
CG24317B

Details and patient eligibility

About

The objective of this observational study is to analyze the factors influencing wound healing after anal fistula surgery and to assess the effectiveness of interventions in improving overall patient outcomes post-surgery. The primary questions this study aims to answer are:

  1. Does the use of the growth factor (New Epi) contribute to accelerating wound healing, reducing the risk of infection, and enhancing patient recovery speed after surgery?
  2. Do other factors, such as infection, nutritional status, diabetes, surgical methods, patient age and overall health, immune status, and lifestyle habits, affect the healing of surgical wounds?

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 18 years old.
  • Have undergone anal fistula surgery with complete surgical records.
  • No significant surgical contraindications, such as:Acute infection or inflammation,Severe cardiopulmonary insufficiency,Coagulation disorders,Immunodeficiency,Local skin lesions.
  • Understand and are willing to participate in the study.Willing to sign the informed consent form.

Exclusion criteria

  • Patients under 18 years of age.
  • Pregnant or breastfeeding women.
  • Individuals with pre-existing severe heart, liver, or kidney diseases.
  • Individuals with active infections or systemic diseases.
  • Individuals who have previously undergone similar surgeries.
  • Individuals with immune dysfunction (such as HIV infection).

Trial design

600 participants in 2 patient groups

Patients using New Epi epidermal growth factor
Description:
Patients using New Epi epidermal growth factor who are over 18 years old, confirmed to require fistula surgery, without significant surgical contraindications, able to understand and willing to participate in the study, and willing to sign the informed consent form.
Treatment:
Other: NewEpi Plus Liquid Wound Dressing
Patients receiving standard wound care
Description:
Patients receiving standard wound care who are over 18 years old, confirmed to require fistula surgery, without significant surgical contraindications, able to understand and willing to participate in the study, and willing to sign the informed consent form.
Treatment:
Other: standard wound care

Trial contacts and locations

0

Loading...

Central trial contact

Chun-Yu Lin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems